Retrophin Inc (NASDAQ:RTRX)

22.43
Delayed Data
As of Mar 22
 -1.30 / -5.48%
Today’s Change
19.77
Today|||52-Week Range
33.00
-0.88%
Year-to-Date

Today’s Trading

Previous close23.73
Today’s open23.55
Day’s range22.42 - 23.73
Volume321,233
Average volume (3 months)364,146
Market cap$931.4M
Data as of 3:59pm ET, 03/22/2019

Growth & Valuation

Earnings growth (last year)+8.57%
Earnings growth (this year)-50.26%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+6.01%
P/E ratioNM
Price/Sales5.57
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...-0.52-6.58%
NSTGNanoString Technolog...-0.79-3.26%
RDUSRadius Health Inc-0.41-2.12%
XONIntrexon Corp-0.39-6.77%
Data as of 4:15pm ET, 03/22/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$164.2M
Annual profit (last year)-$102.7M
Net profit margin-62.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Eric Dube
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts